Sabra Healthcare REIT, Inc. $SBRA Shares Acquired by Advisors Capital Management LLC

Advisors Capital Management LLC increased its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 2.8% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 2,309,654 shares of the real estate investment trust’s stock after acquiring an additional 62,689 shares during the period. Advisors Capital Management LLC owned approximately 0.96% of Sabra Healthcare REIT worth $43,052,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of SBRA. Engineers Gate Manager LP boosted its position in Sabra Healthcare REIT by 3,190.3% in the 2nd quarter. Engineers Gate Manager LP now owns 3,179,303 shares of the real estate investment trust’s stock valued at $58,626,000 after buying an additional 3,082,677 shares during the last quarter. Norges Bank acquired a new position in shares of Sabra Healthcare REIT in the second quarter worth about $54,385,000. Balyasny Asset Management L.P. purchased a new position in Sabra Healthcare REIT in the second quarter valued at about $49,955,000. Bank of Montreal Can boosted its holdings in Sabra Healthcare REIT by 244.1% in the second quarter. Bank of Montreal Can now owns 2,575,969 shares of the real estate investment trust’s stock valued at $47,501,000 after purchasing an additional 1,827,361 shares during the last quarter. Finally, Qube Research & Technologies Ltd grew its stake in Sabra Healthcare REIT by 856.5% during the 2nd quarter. Qube Research & Technologies Ltd now owns 1,398,965 shares of the real estate investment trust’s stock valued at $25,797,000 after purchasing an additional 1,252,708 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Cantor Fitzgerald increased their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research note on Tuesday. Wells Fargo & Company increased their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research note on Thursday, January 22nd. Wall Street Zen cut Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research note on Friday, January 23rd. Finally, UBS Group initiated coverage on Sabra Healthcare REIT in a research report on Tuesday, November 18th. They issued a “neutral” rating and a $20.00 target price for the company. Four analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, Sabra Healthcare REIT presently has a consensus rating of “Hold” and a consensus target price of $21.22.

Sabra Healthcare REIT Trading Up 2.1%

Shares of NASDAQ:SBRA opened at $20.59 on Wednesday. The company has a 50 day moving average of $19.08 and a 200-day moving average of $18.80. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90. The firm has a market cap of $5.19 billion, a P/E ratio of 32.17, a P/E/G ratio of 1.42 and a beta of 0.67. Sabra Healthcare REIT, Inc. has a twelve month low of $15.60 and a twelve month high of $20.70.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The firm had revenue of $201.35 million for the quarter, compared to the consensus estimate of $201.97 million. During the same period in the prior year, the business earned $0.36 EPS. The company’s quarterly revenue was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 27th. Investors of record on Friday, February 13th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 5.8%. The ex-dividend date of this dividend is Friday, February 13th. Sabra Healthcare REIT’s payout ratio is presently 187.50%.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.